Home/ Supplements/ Electrolytes/ Refluxin

Refluxin

product on market Tablet or Pill Cardiovascular Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This product contains essential minerals including calcium, magnesium, and potassium, which support various physiological functions. Research evidence for these ingredients is generally strong regarding general health, though evidence coverage for this specific formulation is limited. The profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Refluxin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
90
Servings
Other Combinations
Product Type
12%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s)
Total Sugars
1 Gram(s)
Calcium
27 mg (2% DV)
12 mg (2% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Potassium
23 mg (1% DV)
Pectin
100 mg
Lecithin
50 mg
Mucin
50 mg

Other Ingredients

Microcrystalline Cellulose Fructose Citric Acid natural Vanilla flavoring Silicon Dioxide Magnesium Stearate Dextrose
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Chew 1 tablet after a meal, or more as directed by a physician. Important: Briefly chew each tablet separately, swallow with a sip of water.

Warnings & Precautions

This product contains: pectin and soy, which are two potential allergens.

Formulation Notes

Refluxin is a scientifically designed formula providing a buoyant gastric "raft" with emollient and mildly antacid characteristics in a pleasant tasting, slightly effervescent fructose-citric acid base.

Gluten free, casein free

Additional Information

Ecological formulas

Metadata

Product Details

UPC / SKU6 96859 13080 9
DSLD Entry Date2023-12-14
Product TypeOther Combinations
FormTablet or Pill
BrandCardiovascular Research
DSLD ID304423
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

Magnesium
Vitabase · Tablet or Pill
100
Natural Magnesium 250 mg
Sunmark · Tablet or Pill
100
Magnesium 250 mg USP
Equaline · Tablet or Pill
100
Magnesium-Oxide
Genesis Products · Tablet or Pill
100
Calcium Pyruvate 750 mg
Martin Avenue Pharmacy · Tablet or Pill
100
View all Electrolytes products →
Electrolytes research Best Electrolytes All Electrolytes products More from Cardiovascular Research View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.